Abukuri DN (2024) Novel biomarkers for Alzheimer’s disease: plasma neurofilament light and cerebrospinal fluid. Int J Alzheimers Dis 2024:6668159. https://doi.org/10.1155/2024/6668159

Article  PubMed  PubMed Central  Google Scholar 

Ahmed T, Gilani AH, Abdollahi M et al (2015) Berberine and neurodegeneration: a review of literature. Pharmacol Rep 67:970–979. https://doi.org/10.1016/j.pharep.2015.03.002

Article  CAS  PubMed  Google Scholar 

Alam M, Ahmed S, Elasbali AM et al (2022) Therapeutic implications of caffeic acid in cancer and neurological diseases. Front Oncol. https://doi.org/10.3389/fonc.2022.860508

Article  PubMed  PubMed Central  Google Scholar 

Alsultan A, Alghamdi WA, Alghamdi J et al (2020) Clinical pharmacology applications in clinical drug development and clinical care: a focus on Saudi Arabia. Saudi Pharm J 28:1217–1227. https://doi.org/10.1016/j.jsps.2020.08.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amanzadeh E, Esmaeili A, Rahgozar S, Nourbakhshnia M (2019) Application of quercetin in neurological disorders: from nutrition to nanomedicine. Rev Neurosci 30:555–572. https://doi.org/10.1515/revneuro-2018-0080

Article  PubMed  Google Scholar 

Anand KS, Dhikav V (2012) Hippocampus in health and disease: an overview. Ann Indian Acad Neurol 15:239–246. https://doi.org/10.4103/0972-2327.104323

Article  PubMed  PubMed Central  Google Scholar 

Angelopoulou E, Pyrgelis ES, Piperi C (2020) Neuroprotective potential of chrysin in Parkinson’s disease: molecular mechanisms and clinical implications. Neurochem Int 132:104612. https://doi.org/10.1016/j.neuint.2019.104612

Article  CAS  PubMed  Google Scholar 

Aslam M, Ladilov Y (2022) Emerging role of cAMP/AMPK signaling. Cells 11:308. https://doi.org/10.3390/cells11020308

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayvaz H, Cabaroglu T, Akyildiz A et al (2022) Anthocyanins: metabolic digestion, bioavailability, therapeutic effects, current pharmaceutical/industrial use, and innovation potential. Antioxidants 12:48. https://doi.org/10.3390/antiox12010048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azargoonjahromi A, Abutalebian F (2024) Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence. Nutr Metab 21:15. https://doi.org/10.1186/s12986-024-00792-1

Article  Google Scholar 

Babbs CF (2014) Choosing inclusion criteria that minimize the time and cost of clinical trials. World J Methodol 4:109–122. https://doi.org/10.5662/wjm.v4.i2.109

Article  PubMed  PubMed Central  Google Scholar 

Balez R, Steiner N, Engel M et al (2016) Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease. Sci Rep 6:31450. https://doi.org/10.1038/srep31450

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhaduri I, Trisal A, Singh AK (2023) Autophagy as a promising therapeutic target in age-associated neurodegenerative disorders. In: Rizvi SI (ed) Emerging anti-aging strategies. Springer Nature, Singapore, pp 41–56

Chapter  Google Scholar 

Bhatti JS, Sehrawat A, Mishra J et al (2022) Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radical Biol Med 184:114–134. https://doi.org/10.1016/j.freeradbiomed.2022.03.019

Article  CAS  Google Scholar 

Bhuia MdS, Rahaman MdM, Islam T et al (2023) Neurobiological effects of gallic acid: current perspectives. Chin Med 18:27. https://doi.org/10.1186/s13020-023-00735-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blagosklonny MV (2023) Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases? Aging 15:6632–6640. https://doi.org/10.18632/aging.204920

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boemi M, Furlan G, Luconi MP (2016) Chapter 29—Glucose metabolism, insulin, and aging: role of nutrition. In: Malavolta M, Mocchegiani E (eds) Molecular basis of nutrition and aging. Academic Press, San Diego, pp 393–409

Chapter  Google Scholar 

Brito DVC, Esteves F, Rajado AT et al (2023) Assessing cognitive decline in the aging brain: lessons from rodent and human studies. NPJ Aging 9:23. https://doi.org/10.1038/s41514-023-00120-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai Z, Wang C, Yang W (2016) Role of berberine in Alzheimer’s disease. NDT 12:2509–2520. https://doi.org/10.2147/NDT.S114846

Article  CAS  Google Scholar 

Cascorbi I (2012) Drug interactions—principles, examples and clinical consequences. Dtsch Arztebl Int 109:546–556. https://doi.org/10.3238/arztebl.2012.0546

Article  PubMed  PubMed Central  Google Scholar 

Castellani RJ, Perry G, Smith MA (2007) The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotox Res 12:269–274. https://doi.org/10.1007/BF03033910

Article  CAS  PubMed  Google Scholar 

Chang CF, Lee YC, Lee KH et al (2016) Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J Biomed Sci 23:72. https://doi.org/10.1186/s12929-016-0290-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Yang Y, Zhang Y (2013) Isobavachalcone and bavachinin from Psoraleae Fructus modulate Aβ42 aggregation process through different mechanisms in vitro. FEBS Lett 587:2930–2935. https://doi.org/10.1016/j.febslet.2013.07.037

Article  CAS  PubMed  Google Scholar 

Chen S, Gan D, Lin S et al (2022) Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms. Theranostics 12:2722–2740. https://doi.org/10.7150/thno.71360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Z, Kang C, Che S et al (2022) Berberine: a promising treatment for neurodegenerative diseases. Front Pharmacol 13:845591. https://doi.org/10.3389/fphar.2022.845591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng YW, Lin YJ, Lin YS et al (2024) Application of blood-based biomarkers of Alzheimer’s disease in clinical practice: recommendations from Taiwan Dementia Society. J Formos Med Assoc. https://doi.org/10.1016/j.jfma.2024.01.018

Article  PubMed  Google Scholar 

Chiang MC, Tsai TY, Wang CJ (2023) The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms. Int J Mol Sci 24:6328. https://doi.org/10.3390/ijms24076328

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa LG, Garrick JM, Roquè PJ, Pellacani C (2016) Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxid Med Cell Longev 2016:e2986796. https://doi.org/10.1155/2016/2986796

Article  CAS  Google Scholar 

Cui Z, Zhao X, Amevor FK et al (2022) Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol. https://doi.org/10.3389/fimmu.2022.943321

Article  PubMed  PubMed Central